Sugar compositions for treating hemophilia A and/or von Willebrand disease

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9707269
APP PUB NO 20150087592A1
SERIAL NO

14399326

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to compositions comprising an isolated sugar for use in the treatment of von Willebrand disease and/or hemophilia A, wherein the sugar is an accessible sugar residue derived from ABO(H) blood group antigen.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CSL BEHRING GMBHMARBURG

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Moses, Michael Graevenwiesbach, DE 14 2998
Schulte, Stefan Marburg, DE 76 678
Spirig, Rolf Bern, CH 7 30
Stoehr, Hans-Arnold Wetter, DE 17 108
Wormsbaecher, Wilfried Kirchhain, DE 2 0
Zollner, Sabine Muri, CH 10 23

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 18, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 18, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00